Client News
Medigene AG Reports Financial Results and Business Update for Q1 2024
CARBIOS Celebrates the Groundbreaking of its PET Biorecycling Plant, a World First, with its Partners
Affluent Medical: 2023 Financial Results and Update on Clinical Activities under Development
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
Medigene Presents Streamlined 6-Day, High Stemness TCR-T Therapy Production Process
Formycon Reports Audited Annual Results for the Financial Year 2023 – Looking Back on a Successful Operative Year and Exceeded Guidance
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
TVM Capital Healthcare Announces EUR 16 Million Investment into neurocare
Medigene AG Launches Capital Increase with Subscription Rights and Backstop Agreement
